We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+13.18%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$247M
AUM Growth
+$20.1M
Cap. Flow
+$1.08M
Cap. Flow %
0.44%
Top 10 Hldgs %
56.55%
Holding
90
New
8
Increased
18
Reduced
14
Closed
17

Top Buys

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$2.55M
2
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
+$1.06M
3
INTC icon
Intel
INTC
+$1.02M
4
T icon
AT&T
T
+$804K
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$738K

Top Sells

Rank Stock Value
1
VZ icon
Verizon
VZ
+$2.61M
2
BABA icon
Alibaba
BABA
+$2.15M
3
GDX icon
VanEck Gold Miners ETF
GDX
+$1.92M
4
AMD icon
Advanced Micro Devices
AMD
+$1.34M
5
PSFE icon
Paysafe
PSFE
+$853K

Sector Composition

Rank Sector Weight
1 Healthcare 39.97%
2 Technology 13.69%
3 Communication Services 7.37%
4 Financials 4.79%
5 Consumer Discretionary 3.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ET icon
51
Energy Transfer Partners
ET
$70.1B
$774K 0.31%
94,000
+72,500
+337% +$659K
AZN icon
52
AstraZeneca
AZN
$263B
$742K 0.3%
6,373
– –
EQ icon
53
Equillium
EQ
$139M
$708K 0.29%
187,666
+2,000
+1% +$10.8K
XLP icon
54
CALL
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.2B
$694K 0.28%
+9,000
New +$652K
AMRN
55
Amarin Corp
AMRN
$299M
$539K 0.22%
8,000
– –
BDX icon
56
Becton Dickinson
BDX
$45.6B
$503K 0.2%
2,050
-1,025
-33% -$246K
BOX icon
57
Box
BOX
$4.37B
$485K 0.2%
18,500
– –
ARNA
58
DELISTED
Arena Pharmaceuticals Inc
ARNA
$465K 0.19%
5,000
– –
OVID icon
59
Ovid Therapeutics
OVID
$414M
$455K 0.18%
141,701
– –
NKTR icon
60
Nektar Therapeutics
NKTR
$2.39B
$423K 0.17%
2,087
– –
LIT icon
61
Global X Lithium & Battery Tech ETF
LIT
$1.51B
$422K 0.17%
5,000
-4,500
-47% -$399K
FCX icon
62
Freeport-McMoran
FCX
$90B
$417K 0.17%
10,000
– –
WBD icon
63
Warner Bros
WBD
$65.9B
$376K 0.15%
15,990
-9,010
-36% -$224K
APTV icon
64
Aptiv
APTV
$12B
$371K 0.15%
2,250
– –
PARA
65
DELISTED
Paramount Global Class B
PARA
$335K 0.14%
11,100
-1,400
-11% -$48.2K
WBA
66
DELISTED
Walgreens Boots Alliance
WBA
$261K 0.11%
5,000
– –
AIRT icon
67
Air T
AIRT
$75.5M
$252K 0.1%
10,004
+333
+3% +$9.05K
LCTX icon
68
Lineage Cell Therapeutics
LCTX
$269M
$208K 0.08%
85,000
-2,000
-2% -$4.68K
MTNB icon
69
Matinas BioPharma
MTNB
$1.88M
$156K 0.06%
3,090
– –
APTX
70
DELISTED
Aptinyx Inc. Common Stock
APTX
$152K 0.06%
57,000
-57,000
-50% -$137K
REGN icon
71
CALL
Regeneron Pharmaceuticals
REGN
$78.5B
$126K 0.05%
+200
New +$123K
IMDX
72
Insight Molecular Diagnostics
IMDX
$150M
$26K 0.01%
607
– –
AMZN icon
73
CALL
Amazon
AMZN
$2.92T
– –
-6,000
Closed -$986K
BABA icon
74
CALL
Alibaba
BABA
$293B
– –
-7,500
Closed -$1.11M
BABA icon
75
Alibaba
BABA
$293B
– –
-14,500
Closed -$2.15M
1 2
3
4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q4 2021 Portfolio in Review

As of Q4 2021, DCF Advisers held 90 positions worth $247M, up 8.9% from $227M the previous quarter. Its ten largest holdings account for 57% of the portfolio.

DCF Advisers's Q4 2021 filing shows 8 new, 18 increased, 14 reduced and 17 closed positions. Its largest new stake was Intel: 20,000 shares worth $1.03M. The largest sale was Verizon, an estimated $2.61M.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 38% a quarter earlier, followed by Technology and Communication Services.

  • DCF Advisers's largest Q4 2021 buy was Intel: 20,000 shares worth $1.03M.
  • DCF Advisers added most to AbbVie in Q4 2021, an estimated $2.55M increase.
  • DCF Advisers's biggest Q4 2021 reduction was Verizon, cutting an estimated $2.61M.
  • DCF Advisers fully exited Alibaba in Q4 2021, selling an estimated $2.15M.
  • DCF Advisers's ten largest holdings make up 57% of its $247M portfolio in Q4 2021.
  • DCF Advisers opened 8 new positions and closed 17 in Q4 2021.
  • DCF Advisers's portfolio value rose 8.9% quarter-over-quarter to $247M.

Based on DCF Advisers's 13F filing for Q4 2021, filed 10 Feb 2022.